US FDA Revisits PD-L1 Biomarker In Gastric, Esophageal Cancers

 
• By Bridget Silverman
  
esophageal cancer
Labeling for PD-1 inhibitors in esophageal cancer could be changed. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers